BRIEF published on 10/08/2025 at 10:15, 1 month 27 days ago Covation Biomaterials Unveils CovationBio® bioPTMEG at K-Show 2025 Sustainable Materials Emission Reduction Covation Biomaterials BioPTMEG Plastics Innovation
BRIEF published on 10/08/2025 at 10:15, 1 month 27 days ago Covation Biomaterials dévoile CovationBio® bioPTMEG au K-Show 2025 Réduction Des Émissions Matériaux Durables BioPTMEG Biomatériaux Covation Innovation Dans Le Domaine Des Plastiques
PRESS RELEASE published on 10/08/2025 at 10:10, 1 month 27 days ago Covation Biomaterials Highlights Milestones for CovationBio® bioPTMEG at K-Show 2025 Covation Biomaterials highlights milestones for CovationBio(R) bioPTMEG at K-Show 2025, showcasing sustainable innovation and future plans for bio-based materials Innovation Sustainability Covation Biomaterials BioPTMEG Bio-based Materials
Published on 12/05/2025 at 02:35, 4 hours 1 minute ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 36 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 31 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 36 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 6 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 45 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 11 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 21 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 26 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 22 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 36 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 36 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 51 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 51 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
